000225.KS
Yuyu Pharma, Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 3,700.00
−1.46%Year over year
Reported trailing growth
- Revenue
- +6.7%
- EBITDA
- -69.6%
- EBIT
- +39.8%
- EPS
- +156.0%
- Free cash flow
- -48.0%
- Operating cash flow
- +20.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +0.5%
- EBITDA
- +69.7%
- EBIT
- +151.6%
- Net income
- -6.5%
- EPS
- +5.1%
- Free cash flow
- -55.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026